Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Applications
Antibody Discovery
ELISA
Western Blot
3D Cell Culture
Spatial Biology
PCR
Quantitative PCR
Digital PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
Application Notes
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Troubleshooting and Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
Cloning and Expression
Library Construction
cDNA Synthesis
RNA
RNA
K-Ras shRNA Plasmid (h)
Supplier Images
Published Figures
K-Ras shRNA Plasmid (h)
K-Ras shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.
Be the first to write a review!
Citations:
(36)
Figures:
(3)
Supplier Page
Supplier Page from
Santa Cruz Biotechnology, Inc. for
K-Ras shRNA Plasmid (h)
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
K-Ras shRNA Plasmid (h)
Company
Santa Cruz Biotechnology, Inc.
Price
$592.00
Supplier Page
View Company Product Page
Catalog Number
sc-35731-SH
Vector Type (Standardized)
Lentiviral
Type
shRNA Plasmid
Species
human
NCBI Full Gene Name
KRAS proto-oncogene, GTPase
NCBI Gene Aliases
'C-K-RAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, K-Ras, K-Ras 2, KI-RAS, KRAS1, KRAS2, NS, NS3, OES, RALD, RASK2, c-Ki-ras, c-Ki-ras2
RNA Type
shRNA Clones
Quantity
20 µg
Add to Compare List
Santa Cruz Biotechnology, Inc.
10410 Finnell Street
Dallas
,
Texas
75220
United States
Phone
: 1-800-457-3801
831-457-3801
Company Profile
Website:
http://www.scbt.com/
Citations (36)
(21)
5-Fluorouracil preferentially sensitizes mutant KRAS non-small cell lung carcinoma cells to TRAIL-induced apoptosis
Molecular oncology
November 1, 2015
Wang H, Yang T, Wu X.
(22)
Stable and efficient transfection of siRNA for mutated KRAS silencing using novel hybrid nanoparticles
Molecular pharmaceutics
December 1, 2014
Lakshmikuttyamma A, Sun Y, Lu B, Undieh AS, Shoyele SA.
(23)
Ral GTPase down-regulation stabilizes and reactivates p53 to inhibit malignant transformation
The Journal of biological chemistry
November 7, 2014
Tecleab A, Zhang X, Sebti SM.
(24)
Cytochrome c oxidase is activated by the oncoprotein Ras and is required for A549 lung adenocarcinoma growth
Molecular cancer
August 23, 2012
Telang S, Nelson KK, Siow DL, Yalcin A, Thornburg JM, Imbert-Fernandez Y, Klarer AC, Farghaly H, Clem BF, Eaton JW,
et al
.
(25)
NF-κB activity is downregulated by KRAS knockdown in SW620 cells via the RAS-ERK-IκBα pathway
Oncology reports
May 1, 2012
Lin G, Tang Z, Ye YB, Chen Q.
(26)
Blimp1 activation by AP-1 in human lung cancer cells promotes a migratory phenotype and is inhibited by the lysyl oxidase propeptide
PloS one
January 1, 2012
Yu Z, Sato S, Trackman PC, Kirsch KH, Sonenshein GE.
(27)
Activation of H-Ras and Rac1 correlates with epidermal growth factor-induced invasion in Hs578T and MDA-MB-231 breast carcinoma cells
Biochemical and biophysical research communications
March 4, 2011
Koh MS, Moon A.
(28)
Suppression of A549 lung cancer cell migration by precursor let-7g microRNA
Molecular medicine reports
November 1, 2010
Park S, Minai-Tehrani A, Xu CX, Chang SH, Woo MA, Noh MS, Lee ES, Lim HT, An GH, Lee KH,
et al
.
(29)
Oncogenic Ras-mediated downregulation of Clast1/LR8 is involved in Ras-mediated neoplastic transformation and tumorigenesis in NIH3T3 cells
Cancer science
September 1, 2010
Ryu SH, Kim KH, Kim HB, Kim MH, Kim NH, Kang Y, Hyun JW, Seo HJ, Jun JY, You HJ.
(30)
Gankyrin plays an essential role in Ras-induced tumorigenesis through regulation of the RhoA/ROCK pathway in mammalian cells
The Journal of clinical investigation
August 1, 2010
Man JH, Liang B, Gu YX, Zhou T, Li AL, Li T, Jin BF, Bai B, Zhang HY, Zhang WN,
et al
.
(31)
Modulation of E-cadherin expression by K-Ras; involvement of DNA methyltransferase-3b
Carcinogenesis
July 1, 2010
Kwon O, Jeong SJ, Kim SO, He L, Lee HG, Jang KL, Osada H, Jung M, Kim BY, Ahn JS.
(32)
The Ras effector RASSF2 controls the PAR-4 tumor suppressor
Molecular and cellular biology
June 1, 2010
Donninger H, Hesson L, Vos M, Beebe K, Gordon L, Sidransky D, Liu JW, Schlegel T, Payne S, Hartmann A,
et al
.
(33)
Overexpression of DDX43 mediates MEK inhibitor resistance through RAS Upregulation in uveal melanoma cells
Molecular cancer therapeutics
January 1, 0001
"Ambrosini G, Khanin R, Carvajal RD, Schwartz GK."
(34)
KRAS Activation in Gastric Adenocarcinoma Stimulates Epithelial-to-Mesenchymal Transition to Cancer Stem-Like Cells and Promotes Metastasis
Molecular cancer research : MCR
January 1, 0001
"Yoon C, Till J, Cho SJ, Chang KK, Lin JX, Huang CM, Ryeom S, Yoon SS."
(35)
The RAS-interacting chaperone UNC119 drives the RASSF6-MDM2-p53 axis and antagonizes RAS-mediated malignant transformation
The Journal of biological chemistry
January 1, 0001
"Shimizu T, Nakamura T, Inaba H, Iwasa H, Maruyama J, Arimoto-Matsuzaki K, Nakata T, Nishina H, Hata Y."
(36)
The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in KRAS-Driven Lung Cancer
Cancers
January 1, 0001
"Lee SH, Jeon Y, Kang JH, Jang H, Lee H, Kim SY."
Page
<<
<
1
2
>
>>
Reviews
Be the First to Write a Review!
K-Ras shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.
Supplier Page
View Company Product Page
$592.00
Product Specs
Company Info
Citations
Reviews
Back To Top